SCHEMBL6614738

SCHEMBL6614738

Cc1ccc(Nc2nc3ccc(CC(=O)O)cc3o2)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.53
IL6 P05231 2/20 0.47
STAT3 P40763 2/20 0.47
GAA P10253 2/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
HPSE Q9Y251 2/20 0.44
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CSNK1D P48730 1/20 0.42
CSNK1G2 P78368 1/20 0.42
PDE4B Q07343 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2437918 0.89 NPC1 (0.56) HDAC6IL6STAT3GAAHPSE
SCHEMBL11640477 0.88 CSNK1D (0.49) IL6STAT3GAAMAPTHPSE
SCHEMBL11637058 0.85 PSEN1 (0.46) IL6STAT3GAAMAPTHPSE
SCHEMBL31430448 0.84 GAA (0.55) HDAC6IL6STAT3GAAMAPT
SCHEMBL14371695 0.82 GAA (0.50) GAAMAPTHPSEALDH1A1CSNK1D
SCHEMBL14626860 0.81 NPC1 (0.54) HDAC6IL6STAT3GAANPC1
SCHEMBL6616110 0.81 HDAC6 (0.62) HDAC6IL6STAT3GAAUSP2
SCHEMBL2429466 0.81 ITGA4 (0.56) IL6STAT3GAAMAPTNPC1
SCHEMBL7659834 0.80 KDM4E (0.52) HDAC6IL6STAT3GAAUSP2
SCHEMBL7429665 0.80 NPC1 (0.53) HDAC6IL6STAT3GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392306-A1 SUBSTITUTED TETRAHYDROISOQUINOLINES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES Aventis Pharma Limited (GB) 2004-03-03 EP disclosed
WO-2002098426-A1 SUBSTITUTED TETRAHYDROISOQUINOLINES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AVENTIS PHARMA LIMTIED (GB) 2002-12-12 WO disclosed